The customer for this innovation is primarily elderly individuals who require assistance with daily living activities, as well as their caregivers and family members who provide support and care for them. Urisens innovation provides reliable and accurate monitoring of elderly individuals urinary output and clinically important parameters.
Urisens technology can be used in various settings, including in-home care, nursing homes, assisted living facilities, and hospitals, to provide reliable and accurate monitoring of elderly individuals’ urinary output and clinically important parameters.
Urisens is a technology aimed at elderly care. It is designed to help caregivers monitor the urinary output of elderly individuals who require assistance with daily living activities. It uses advanced technology to detect and alert caregivers when a change of a diaper is needed and measures important clinical parameters.
In addition to incontinence management, Urisens can help in preventive care. Early detection of urinary tract infections (UTIs) and other medical conditions can be critical in preventing complications and ensuring timely treatment. Urisens technology can help detect changes in urinary patterns, which may be an indicator of a UTI or other medical condition, allowing caregivers to take prompt action.
Behind the innovation: Urisens solves monitoring elderly individuals’ urinary output and clinically important parameters
Urisens technology can help elderly individuals maintain their dignity and independence by providing discreet monitoring of urinary output and urine parameters. Caregivers can be overwhelmed by the demands of caring for elderly individuals with incontinence. Urisens technology can reduce the caregiver burden by providing reliable monitoring, which can help caregivers to plan and prioritize their care activities. Urisens can improve the quality of care and quality of life for both elderly individuals and their caregivers, while also helping to prevent medical complications and reduce healthcare costs.
The market situation now and the next steps
Urisens is currently a Business Finland R2B project working on the technology proof of concept in Aalto University. Urisens is aiming for the Nordic and EU market. The potential market situation for Urisens technology aimed at elderly care is significant. According to the United Nations, the global population aged 60 years and older is expected to more than double by 2050, reaching nearly 2.1 billion people. As the elderly population continues to grow, the demand for innovative solutions to support elderly care is likely to increase.
In addition, the market for incontinence management products is already quite large, with estimates suggesting that the global incontinence products market size was valued at USD 15.1 billion in 2020 and is projected to reach USD 23.5 billion by 2027.
Our impact for society
Urisens: Our impact in society would be increased efficiency in healthcare and technological innovation. Real-time monitoring of urinary movements can help to identify changes in patterns that may be indicative of a medical condition, enabling earlier intervention and treatment. This can lead to reduced healthcare costs and better outcomes for elderly individuals. The development and use of Urisens technology represents a significant technological innovation, which can drive further development and progress in the field of elderly care.
Our impact in users and customers would be improved quality of life for elderly individuals and reduced caregiver burden. The use of Urisens technology can help elderly individuals maintain their dignity and independence, while also reducing discomfort and minimizing the need for frequent diaper changes. Urisens technology can help caregivers to manage incontinence more effectively, reducing the physical and emotional burden of caring for elderly individuals with incontinence.
Our Sustainable Development Goals
SDG 3 – Good Health and Well-being*: The use of Urisens technology can help to improve the health and well-being of elderly individuals by providing real-time monitoring and alerting capabilities, which can help to identify and manage medical conditions related to incontinence.
SDG 9 – Industry, Innovation and Infrastructure*: The development and use of Urisens technology represents a significant innovation in the field of elderly care, which can drive further progress in this area and contribute to the development of new technologies and solutions.
SDG 10 – Reduced Inequalities*: Incontinence can be a stigmatizing condition that can lead to social isolation and exclusion for elderly individuals. The use of Urisens technology can help to reduce this inequality by providing discreet and dignified monitoring of urinary movements.
SDG 12 – Responsible Consumption and Production*: The use of Urisens technology can help to reduce waste and promote responsible consumption by minimizing the need for frequent diaper changes and reducing the environmental impact of incontinence products.
SDG 17 – Partnerships for the Goals*: The development and implementation of Urisens technology requires collaboration between different stakeholders, including healthcare providers, caregivers, and technology developers. This can contribute to the development of partnerships and collaborations that support the achievement of the SDGs.
*Source: United Nations: sdgs.un.org/goals
How people’s lives will change with Urisens’ MedTech innovation
Urisens: The introduction of Urisens technology aimed at elderly care can have a significant impact on people’s lives in the following ways: increased independence and dignity for elderly individuals, improved quality of life for elderly individuals, reduced burden on caregivers, early detection of medical conditions and increased peace of mind for family members. Our solution is more comfortable for patients and also easier to use for caregivers.
The benefits and help we have gotten from Aalto Startup Center
Urisens: So far, I have had great benefits in networking opportunities, networking with other entrepreneurs, mentors, and investors as well as building relationships, finding potential collaborators and insights from experienced professionals. I’ve also had access to business development resources. Knowledge sharing and learning opportunities have been great as well as learning about trends and best practices.